Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.80x is 88% above its 5-year average of -22.78x, near the high end of its 5-year range (-129.83x–2.64x).
89.49% below its 12-month average of -1.48x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -0.77x.
INTEREST COVERAGE RATIO
-2.80x
INTEREST COVERAGE RATIO AVG TTM
-1.48x
INTEREST COVERAGE RATIO AVG 3Y
-8.86x
INTEREST COVERAGE RATIO AVG 5Y
-22.78x
INTEREST COVERAGE RATIO AVG 10Y
-19.09x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-89.49%
CURRENT VS 3Y AVG
+68.40%
CURRENT VS 5Y AVG
+87.71%
CURRENT VS 10Y AVG
+85.33%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.31x
median of 424 covered companies
CURRENT VS SECTOR MEDIAN
+47.32%
vs the sector median at left
iRhythm Technologies, Inc.
Market Cap
$3.52B
Interest Coverage Ratio
-2.80x
TTM Avg
-1.48x
3Y Avg
-8.86x
5Y Avg
-22.78x
Market Cap
$3.56B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.44B
Interest Coverage Ratio
N/A
TTM Avg
407.95x
3Y Avg
407.95x
5Y Avg
407.95x
Market Cap
$3.41B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39B
Interest Coverage Ratio
-99.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.12B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.10B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iRhythm Technologies, Inc. (IRTC) | $3.52B | -2.80x | -1.48x | -8.86x | -22.78x |
| Celcuity Inc. (CELC)vs › | $3.55B | -10.04x | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.56B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | N/A | 407.95x | 407.95x | 407.95x |
| CareDx, Inc (CDNA)vs › | $3.41B | N/A | 0.59x | 0.59x | 0.59x |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.39B | -99.92x | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.12B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.10B | N/A | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | -1.01x | N/A | N/A | N/A |
Interest Coverage
-2.8x
Debt/Equity
3.91
Current Ratio
3.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -0.77x |
| 2026-03-31 | -3.60x |
| 2025-12-31 | 2.64x |
| 2025-09-30 | -1.22x |
| 2025-06-30 | -4.43x |
| 2025-03-31 | -9.86x |
| 2024-12-31 | -1.23x |
| 2024-09-30 | -15.11x |
| 2024-06-30 | -6.94x |
| 2024-03-31 | -13.33x |
| 2023-12-31 | -41.64x |
| 2023-09-30 | -29.78x |
| 2023-06-30 | -22.68x |
| 2023-03-31 | -41.58x |
| 2022-12-31 | -20.43x |
| 2022-09-30 | -34.34x |
| 2022-06-30 | -48.65x |
| 2022-03-31 | -23.93x |
| 2021-12-31 | -129.83x |
| 2021-09-30 | -83.45x |
| 2021-06-30 | -55.35x |
| 2021-03-31 | -82.00x |
| 2020-12-31 | -25.62x |
| 2020-09-30 | -12.39x |
| 2020-06-30 | -52.92x |
| 2020-03-31 | -24.14x |
| 2019-12-31 | -46.04x |
| 2019-09-30 | -44.65x |
| 2019-06-30 | -24.01x |
| 2019-03-31 | -20.06x |
| 2018-12-31 | -21.59x |
| 2018-09-30 | -10.71x |
| 2018-06-30 | -13.56x |
| 2018-03-31 | -12.40x |
| 2017-12-31 | -12.29x |
| 2017-09-30 | -6.94x |
| 2017-06-30 | -7.06x |
| 2017-03-31 | -5.77x |
| 2016-12-31 | -5.06x |
| 2016-09-30 | -3.30x |
| 2016-06-30 | -4.60x |
| 2016-03-31 | -6.13x |
| 2015-12-31 | -11.85x |
| 2015-09-30 | -24.77x |
